Global Vaccine Combinations Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2022 –2029 |
 Market Size (Base Year) |
USD 5.94 Billion |
 Market Size (Forecast Year) |
USD 9.76 Billion |
 CAGR |
% |
| Major Markets Players |
>全球疫苗组合市场，按药物类型（Adacel、Vaxelis、Twinrix、Quadracel、MMR II、Comvax、其他）、应用（白喉预防、流感嗜血杆菌预防、甲型肝炎预防、乙型肝炎预防、腮腺炎预防、麻疹预防、脊髓灰质炎预防、百日咳预防、风疹预防、破伤风预防、其他）、产品类型（两种组合、三种组合、四种组合、六种组合）、人口统计（成人、儿科）、类型（亚单位、重组、多糖和结合疫苗、减毒活疫苗、灭活疫苗、类毒素疫苗、DNA 疫苗）、种类（常规疫苗、推荐疫苗、必需疫苗）、给药途径（注射、口服、鼻腔）、最终用户（医院、专科诊所、家庭护理等）、分销渠道（医院药房、零售药房、网上药房等）——行业趋势和预测（至 2029 年）
市场分析和规模
单独的白喉、破伤风和百日咳 (DTP) 疫苗被合并成一种产品，以产生用于预防多种疾病的组合疫苗。疫苗是与人体自身免疫系统协同作用的产品，可增强对有害微生物的保护，从而降低患病几率。已经开发出针对危及生命的疾病的疫苗，每年可避免约 200-300 万人死于破伤风、白喉、百日咳、麻疹和流感等疾病。
Data Bridge Market Research 分析称，疫苗组合市场在 2021 年的价值为 59.4 亿美元，预计到 2029 年将达到 97.6 亿美元，在 2022 年至 2029 年的预测期内复合年增长率为 6.40%。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。
报告范围和市场细分
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
历史岁月 |
2020（可定制为 2014 - 2019） |
|
定量单位 |
收入（单位：十亿美元）、销量（单位：台）、定价（美元） |
|
涵盖的领域 |
药品类型（Adacel、Vaxelis、Twinrix、Quadracel、MMR II、Comvax、其他）、用途（白喉预防、流感嗜血杆菌预防、甲型肝炎预防、乙型肝炎预防、腮腺炎预防、麻疹预防、脊髓灰质炎预防、百日咳预防、风疹预防、破伤风预防、其他）、产品类型（二联、三联、四联、六联）、人口统计（成人、儿童）、类型（亚单位、重组、多糖和结合疫苗、减毒活疫苗、灭活疫苗、类毒素疫苗、DNA 疫苗）、种类（常规疫苗、推荐疫苗、必接种疫苗）、给药途径（注射、口服、鼻腔）、最终用户（医院、专科诊所、家庭护理、其他）、分销渠道（医院药房、零售药房、网上药房、其他） |
|
覆盖国家 |
北美洲的美国、加拿大和墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲其他地区 |
|
涵盖的市场参与者 |
Bio Farma（印度尼西亚）、Bharat Biotech（印度）、Serum Institute of India Pvt. Ltd.（印度）、Biological E Limited（印度）、诺华公司（瑞士）、辉瑞公司（美国）、葛兰素史克公司（英国）、武田药品工业株式会社（日本）、强生公司（美国）、赛诺菲（法国）、默克公司（美国）、百特（美国）、CSL Limited（澳大利亚）、雅培（美国）、F. Hoffmann-La Roche Ltd.（瑞士）、第一三共株式会社（日本）、EMERGENT（美国）、Dynavax Technologies（美国）、Valneva SE（法国）、Bavarian Nordic A/S（丹麦）、Panacea Biotec（印度）、三菱田边制药株式会社（日本） |
|
市场机会 |
|
市场定义
疫苗会引起抗体-抗原反应，有助于产生对病原体的抵抗力。重组疫苗、结合疫苗、减毒活疫苗、灭活疫苗、类毒素疫苗和其他疫苗都是疫苗类型。疫苗组合整合了抗原，可预防引起相同疾病的多种传染性病原体。这减少了控制某些疾病所需的注射次数。
疫苗组合市场动态
驱动程序
- 传染病发病率不断上升
The rising prevalence of infectious diseases is anticipated to influence the vaccine combinations? market's growth. As per the world health organization (WHO), nearly 85 percent of infants (116 million) worldwide received three doses of the diphtheria-tetanus-pertussis (DTP3) vaccination, which protects them from infectious diseases that can cause serious illness, disability, or death. In addition, 125 nations achieved DTP3 vaccination coverage of at least 90% in 2019.
- Rising awareness about immunization
The increasing awareness about immunization and vaccination benefits in emerging regions is expected to flourish the 'market's growth rate during the forecast period of 2022-2029. With improved healthcare awareness, the focus on immunization has shifted significantly, and a variety of government agencies are working to achieve this goal. For instance, Immunize Australia is an Australian government programme that helps people buy immunizations. The National Immunization Program (NIP) Schedule is also implemented, which now contains immunizations for 16 illnesses, including diphtheria, measles and whooping cough (pertussis), as well as vaccines that have just recently been discovered, such as the meningococcal ACWY and HPV vaccines. From birth, every Australian must adhere to this programme.
Furthermore, rising healthcare expenditure and growing incidences of pneumonia will expand the vaccine combinations? market. Additionally, increasing geriatric population and favourable reimbursement policies will result in the expansion of vaccine combinations? market.
Opportunities
- Increase in the number of research and development activities
Moreover, the market's growth is fueled by an increase in the number of research and development activities. Also, company investments and government funding are encouraging R&D sector for launching novel products. This will provide beneficial opportunities for the vaccine combinations? market growth.
Moreover, rising investment for the development of advanced technologies and an increase in the number of emerging markets will provide beneficial opportunities for the vaccine combinations? market growth during the forecast period.
Restraints/Challenges
- Misinformation about vaccine
Human nature attempts to reason, better grasp, and fill in the gaps when there are knowledge gaps or unresolved science, which leads to misinformation. According to new data, approximately 6,000 people were hospitalised around the world in the first three months of 2020 as a result of coronavirus misinformation, according to new data. Nearly 800 people may have perished as a result of COVID-19 misinformation during this time. Governments, funding agencies, vaccine makers and suppliers, and other stakeholders are all concerned about vaccination misinformation and disinformation. Due to vaccination misinformation, poor acceptance rates result in decreased market penetration of effective and safe vaccines, which could have a negative impact on the market.
On the other hand, the high cost associated with the vaccine combinations is anticipated to obstruct the 'market's growth rate. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the vaccine combinations? market. Additionally, side effects of vaccine combinations? and stringent government regulations will act as market restrain and further impede the growth rate of market during the forecast period of 2022-2029.
This vaccine combinations? market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the vaccine combinations? market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Patient Epidemiology Analysis
Vaccine combinations? market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, and adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
COVID-19 Impact on Vaccine Combinations Market
The pandemic of COVID-19 altered the market dynamics for vaccinations. The traditional vaccination market shrank slightly in 2020, as the focus changed from common vaccines to COVID-19 vaccines. As per the UNICEF COVID-19 Vaccine Market Dashboard, at least one country regulatory body has licensed 28 COVID-19 vaccines for use globally. Eight vaccines have been added to the World Health Organization's Emergency Use List (EUL). In total, 21.1 billion doses of COVID-19 vaccinations have been secured worldwide.
Recent Development
- In October 2021, Pfizer and BioNTech had announced the U.S. Food and Drug Administration (FDA) approval for emergency use of a COVID-19 vaccine in children ages 5 through 11 Years. The vaccination should be given in two 10-g doses 21 days apart to this age group. The 10-g dose level was chosen after thorough consideration of the evidence on safety, tolerability, and immunogenicity. This is the first COVID-19 vaccine to be approved in the United States for children aged 5 to 11.
Global Vaccine Combinations Market Scope
The vaccine combinations? market is segmented on the basis of drug type, application, product type, demographic, type, kind, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Drug Type
- Adacel
- Vaxelis
- Twinrix
- Quadracel
- M-M-R II
- Comvax
- Others
Application
- Diphtheria Prophylaxis
- Haemophilus influenzae Prophylaxis
- Hepatitis A Prophylaxis
- Hepatitis B Prevention
- Mumps Prophylaxis
- Measles Prophylaxis
- Poliomyelitis Prophylaxis
- Pertussis Prophylaxis
- Rubella Prophylaxis
- Tetanus Prophylaxis
- Others
Product Type
- Two Combinations
- Three Combinations
- Four Combinations
- Six Combinations
Demographic
- Adult
- Pediatrics
Type
- Subunit
- Recombinant
- Polysaccharide and Conjugate Vaccines
- Live-Attenuated Vaccines
- Inactivated Vaccines
- Toxoid Vaccines
- DNA Vaccines
Kind
- Routine Vaccine
- Recommended Vaccine
- Required Vaccine
Route of Administration
- Injectable
- Oral
- Nasal
End-Users
- Hospitals
- Specialty Clinics
- Homecare
- Others
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
Vaccine Combinations Market Regional Analysis/Insights
The vaccine combinations? market is analysed and market size insights and trends are provided by country, drug type, application, product type, demographic, type, kind, route of administration, end-users and distribution channel as referenced above.
The countries covered in the vaccine combinations? market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
North America dominates the vaccine combinations? market because of the rising number of research and development activities in this region. Additionally, growing presence of major key players and well-established healthcare infrastructure will further propel the 'market's growth rate in this region.
Asia-Pacific is expected to grow during the forecast period of 2022-2029 due to rising healthcare expenditure and improvements in healthcare infrastructure in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Vaccine Combinations Market Share Analysis
The vaccine combinations? market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to vaccine combinations? market.
Some of the major players operating in the vaccine combinations? market are:
- Bio Farma (Indonesia)
- Bharat Biotech (India)
- Serum Institute of India Pvt. Ltd. (India)
- Biological E Limited (India)
- Novartis AG (Switzerland)
- Pfizer Inc. (US)
- GlaxoSmithKline plc (UK)
- Takeda Pharmaceutical Company Limited (Japan)
- Johnson & Johnson Private Limited (US)
- Sanofi (France)
- Merck & Co., Inc. (US)
- Baxter (US)
- CSL Limited (Australia)
- Abbott (US)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- DAIICHI SANKYO COMPANY, LIMITED (Japan)
- EMERGENT (US)
- Dynavax Technologies (US)
- Valneva SE (France)
- Bavarian Nordic A/S (Denmark)
- Panacea Biotec (India)
- Mitsubishi Tanabe Pharma Corporation (Japan)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
